Briacell TherapeuticsBCTX
13F holders, Q2 2026 (June 30)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Briacell Therapeutics Corp. (BCTX) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 0 sold out. The largest holder was FNY Investment Advisers, LLC ($0).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 10778Y302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2026: 10 shares bought, net +10 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| FNY Investment Advisers, LLC | 0.00% | New | 10 | $0 |
"% of holder's portfolio" is BCTX's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.